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ABSTRACT
Most eukaryotic mRNAs are monocistronic and
translated by cap-dependent initiation. LINE-1 RNA
is exceptional because it is naturally dicistronic,
encoding two proteins essential for retrotransposi-
tion, ORF1p and ORF2p. Here, we show that
sequences upstream of ORF1 and ORF2 in mouse
L1 function as internal ribosome entry sites
(IRESes). Deletion analysis of the ORF1 IRES indi-
cates that RNA structure is critical for its function.
Conversely, the ORF2 IRES localizes to 53 nt near
the 30 end of ORF1, and appears to depend upon
sequence rather than structure. The 40 nt intergenic
region(IGR)isnotessentialforORF2IRESfunctionor
retrotransposition. Because of strong cis-preference
for both proteins during L1 retrotransposition, cor-
rect stoichiometry of the two proteins can only be
achievedpost-transcriptionally.Althoughtheprecise
stoichiometry is unknown, the retrotransposition
intermediate likely contains hundreds of ORF1ps
for every ORF2p, together with one L1 RNA. IRES-
mediated translation initiation is a well-established
mechanism of message-specific regulation, hence,
unique mechanisms for the recognition and control
of these two IRESes in the L1 RNA could explain dif-
ferencesintranslationalefficiencyofORF1andORF2.
In addition, translational regulation may provide an
additional layer of control on L1 retrotransposition
efficiency, thereby protecting the integrity of the
genome.
INTRODUCTION
LINE-1, or L1, is an autonomous retrotransposon that has
ampliﬁed to high copy number in mammalian genomes.
There are at least 599000 copies of mouse L1 that are inter-
spersed in all chromosomes, and together comprise 19% of the
genomic DNA (1). Most individual L1 insertions are the trun-
cated, rearranged or otherwise inactivated progeny of a much
smaller number of retrotransposition-competent, active copies
of L1 (2). Recent L1 insertions causing mutant phenotypes,
such as human hemophilia and the spastic mouse document
that L1 is replicating in present-day mammals [reviewed
in (3)].
Retrotransposition-competent L1s are  6500 nt in length
and encode two proteins (Figure 1A). L1 retrotrans-
position begins with transcription of one of the full-length
active copies. This natural dicistronic transcript acts ﬁrst as
the mRNA for translation of the two L1-encoded proteins,
ORF1p and ORF2p, and later as the template for RT.
Both ORF1p and ORF2p are required for retrotransposition.
ORF1p is a nucleic acid binding protein (4–7) with essential
nucleic acid chaperone activity (8,9). ORF2p provides the
enzymatic activities of endonuclease (10) and reverse tran-
scriptase (11) for target-site primed reverse transcription
[TPRT (12)]; TPRT is the mechanism used by L1 and other
non-LTR retrotransposons to insert a new copy into genomic
DNA (13). Because both L1-encoded proteins are required in
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be translated from the primary distronic transcript. This raises
questions about how translation of the L1 proteins is initiated.
Routine translation of the majority of mRNAs in eukaryotic
cells is initiated by a cap-dependent mechanism. This involves
recognitionand binding of the cap structure (m
7GpppN) on the
50 ends of mRNAs by the eukaryotic translation initiation
factor, eIF4F. Upon binding an mRNA, eIF4F recruits the
small ribosomal subunit and additional initiation factors,
and then this 43S complex scans 50–30 until the ﬁrst AUG
initiation codon is encountered. The 60S subunit is then
recruited and elongation begins (16).
Although ORF1 is proximal to the 50 end of the RNA and
hence the presumed cap, initiation of its translation by a cap-
dependent mechanism is likely to be problematic. The ﬁrst
AUGliesatleast300ntdownstreamofthe50 endofL1mRNA
in the TF-type element studied here because the transcriptional
promoter lies in a repeated region known as the TF monomer
(17). In TFspa (18) any one of the 7.2 monomers may theore-
tically be used to initiate transcription, and TFspa itself retro-
transposedsuccessfully witha 50-untranslatedregion(50-UTR)
of at least 1786 nt (18,19). The variability of the length of the
50-UTR and the highly stable secondary structures associated
with even the shortest 50-UTR would be expected to lead to
dramatic ﬂuctuations in the efﬁciency of ribosome scanning
and hence the initiation of translation of ORF1. Highly struc-
tured 50-UTRs are known to represent a signiﬁcant barrier to
scanning ribosomes. One way around this difﬁculty of scan-
ning through long, highly structured 50-UTRs is to recruit the
40S subunit directly, using internal ribosome entry sites
(IRES) [reviewed in (20,21)].
ORF2, on the other hand, is the second cistron in the dicis-
tronic L1 mRNA, and its AUG is separated from the termina-
tion codon of ORF1 by a 40 nt intergenic region (IGR). This
arrangement alone makes it unlikely that ORF2 is translated
by a classical cap-dependent mechanism; the stringent cis-
requirement for ORF2p during L1 retrotransposition (14,15)
eliminates the possibility that a truncated L1 RNA is the nor-
mal mechanism for ORF2 translation. Several other mechan-
isms could explain translational initiation of ORF2, including:
a ribosomal frameshift at the end of ORF1, since the two open
reading frames (ORFs) in mouse L1 overlap by 14 nt (22);
ribosome reinitiation, which follows translation of an
upstream ORF (uORF), in this case ORF1 (23); and ribosomal
shunting, as used for translation of the adenovirus late mRNAs
(24). All of these mechanisms rely on recognition of the 50 cap
by eIF4F. Alternatively, ORF2 could be initiated using an
IRES, which is cap-independent.
Here we test sequences upstream of both ORF1 and ORF2
in mouse L1 for IRES activity. The results of dicistronic
reporter gene assays provide evidence for an IRES upstream
of both ORF1 and ORF2. Neither IRES activity is explained
by artifactual cryptic promoter or splicing activities. Dicistro-
nic assays were also used to map the functional IRES for each
ORF, revealing that the ORF1 IRES encompasses  300 nt,
whereas the ORF2 IRES localizes to a 53 nt region of the
ORF1 coding sequence. Additionally, we show that the IGR is
not required for ORF2 IRES function or L1 retrotransposition
and eliminate ribosomal frameshifting as the mechanism of
translation of ORF2 in mouse L1. These ﬁndings are
placed into the context of L1 retrotransposition and have
implications for the evolution of L1 and its replicative success
in mammals.
MATERIALS AND METHODS
Plasmid constructions
L1 sequences were tested for IRES activity using the dicis-
tronic reporter vector pRF (25), which was obtained from
Figure1.AnIRESupstreamofORF1andORF2inmouseL1.(A)Schematicof
the RNA that created L1spa: tandem boxes on the left represent 7.2 copies of a
212 nt repeatedmotifknownastheTFmonomerwhichcontainsa promoterfor
transcription (18); these are followed by a 257 nt 50-UTR (line); ORF1, which
overlapswithORF2 by14 nt,althoughthe UAA terminationcodonofORF1 is
separated from the first AUG in ORF2 by a 40 nt IGR; ORF2; a 30-UTR (line)
and a polyA tail (An). Note that the 50 end of each L1 mRNA depends upon
which monomerwasusedtoinitiatetranscription,thusthesequencesupstream
of the ORF1 AUG can differ dramatically in length and base composition
(monomer sequences are 65% GC, whereas the remaining 50-UTR is 47%
GC). Regions of L1spa tested for IRES activity using the dicistronic reporter
gene assay are delineated. (B) Schematicof the pRF dicistronic reportervector
containing firefly (Fluc) and Renilla (Rluc) luciferase genes. The dicistronic
mRNA is transcribed by an SV40 promoter/enhancer sequence in mouse cells
and by a T7 promoter in vitro. Insertion of DEMCV upstream of the test
sequence greatly reduces translation of Fluc by read-through or reinitiation
from Rluc (28). (C) Relative lucificerase activity (to pRF without an
insert ± SD) obtained from pRF containing 400 or 201 nt upstream of the
ORF1 (400-1 UTR) or ORF2 (201-1 IGR) AUG or various sequences further
30 in L1. These are named by their lengths and are from the 30 end of ORF2
(202,47,220,140)orthe30-UTR(312,191);theirGCcontentsvarybetween38
and 49%. The knownCricket ParalysisVirus intergenic IRES[CrPV (28)] was
included as a positive control.
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using the oligonucleotide primers listed in Supplementary
Table 1, then cloned into pGEM-TA (Promega). The inserts
were recovered using EcoRI and NcoI, and then moved into
the IGR of pRF (Figure 1B) to generate the plasmids pRF-1 to
pRF-18.ForpRF-19topRF-22,multiplemutationswereintro-
duced into the pGEM-TA clone carrying the 138-1 IGR insert
using QuikChange  Multi Site-Directed Mutagenesis Kit
(Stratagene), and the mutagenized inserts were moved as
restriction fragments into pRF as described above. The
TrkB construct contains the full-length 50-UTR from the
ﬁrst promoter in mouse TrkB (26).
Plasmids for the promoterless reporter assays were based on
RFA30 (27). Inserts were either made by direct ampliﬁcation of
L1spa (18) using the oligonucleotide primers listed in Supple-
mentary Table 1, or by excising inserts from pGEM-TA inter-
mediate clones. All inserts were moved into the promoterless
vector using EcoRI and NcoI.
Plasmids for in vitro studies using rabbit reticulocyte
lysates, T7-EMCV/Fluc-L1 50-UTR /Rluc and T7-EMCV/
Fluc-L1 200IGR/Rluc, were created by moving the EcoRI/
SalI fragment from pRF-2 or pRF-13, containing the 299-1
UTR or the 201-1 IGR from L1, respectively, together with the
adjacent Fluc gene into pGEM 3Z, to make the intermediate
vectors, pGEM-50-UTR Fluc and pGEM-200IGR Fluc. A PCR
fragment containing the encephalomyocarditis virus (EMCV)
IRES and the Rluc gene was ampliﬁed from T7-EMCV/
Fluc-CrPV (Cricket Paralysis Virus) 50 nc/Rluc (28) with
EMCVEX.for and Rluc.rev primers (Supplementary Table
1). The product was digested with EcoRI, then cloned into
the EcoRI sites of pGEM -50-UTR Fluc and pGEM-200IGR
Fluc. To create T7-DEMCV/Fluc-L1 50-UTR /Rluc and T7-
DEMCV/Fluc-L1 200IGR/Rluc constructs, the EMCV IRES
was replaced with an inactive form of the EMCV IRES,
DEMCV. DEMCV was ampliﬁed by PCR from T7
DEMCV/Fluc-CrPV 50 nc/Rluc using EMCVEX.for and
Rluc.rev as the primers, digested with EcoRI and KpnI,
then cloned into T7-EMCV/Fluc-L1 50-UTR /Rluc and T7-
EMCV/Fluc-L1 200IGR/Rluc.
TFC-containing plasmids for autonomous retrotransposition
(9) were mutagenized in the vicinity of the ORF2 AUG to test
for effects on L1 retrotransposition. These mutations were ﬁrst
made in pTN201 (18) and later moved as restriction fragments
into TFC. The PCR products were digested with NotI/NsiI, and
then ligated into an intermediate vector, pDB25, which con-
tains the NotI/BclI fragment of pTN201 in pET28A, for ease
of cloning. The entire NotI/BclI fragment with the mutation
was then used to replace the NotI/BclI fragment of pTN201. In
order to examine the effects of mutations in the vicinity of the
ﬁrst AUG of ORF2 on retrotransposition, a unique HpaI site
was introduced into pTN201 by making a silent substitution of
G for the T at nt nine (if A of the ﬁrst AUG in ORF1 is nt one).
For this, the PstI/SspI fragment from pTN201 was subcloned
into pGEM 3Z, creating pGEM-int. Separate PCR ampliﬁca-
tions were used to amplify the partial ORF1 and ORF2 frag-
ments with an HpaI site by using the primer pairs listed in
Supplementary Table 1. The PCR fragments were digested
with PstI/HpaI, or HpaI/KpnI for partial ORF1 and partial
ORF2, respectively, then those fragments were ligated into
PstI/KpnI-digested pGEM-int. The PstI/StuI fragment from
this subclone was recovered, then ligated into pDB25 to obtain
pET-int Hpa. Various mutants in the IGR were PCR ampliﬁed,
digested with PstI/HpaI and cloned into pET-int Hpa. Those
mutations, as well as mut1 made by site-directed mutagenesis
of pDB44 as described for pRF-19 were then moved into L1
TFC as an NsiI–EcoRV restriction fragment ﬁrst into the inter-
mediate pDB46 and then recovered with NheI and NotI into
pCEP-puro (9) forretrotransposition analysis because pTN201
retrotransposition frequencies were too low to give reliable
differences among mutants in our hands.
Allof the constructionswere veriﬁed by restrictionmapping
aswell asby DNA sequencingacrossjunctions between vector
and insert. All mutations were veriﬁed by DNA sequencing.
Plasmid names and the primers used to generate them are
listed in Supplementary Table 2.
DNA transfection
An aliquot of 1 · 10
5 LTK
  cells were seeded in each well of
a 24-well plate the day before transfection. Cells were trans-
fected with 0.8 mg DNA using LipoFectamine 2000 as recom-
mended (Invitrogen). Cells were harvested 48 h post-
transfection, washed with phosphate-buffered saline (PBS),
then lysed in 100 ml of Passive Lysis Buffer (Promega).
In vitro transcription and RNA transfection
A total of 1 mg of pRF-1 and pRF-13 were linearized with
BamHI, and transcribed in vitro using the mMESSAGE
mMACHINE T7 Ultra  kit (Ambion). An aliquot of
1 · 10
5 LTK
  cells were seeded in each well of a 24-well
plate one day before transfection. A total of 1.6 mg of RNA
were transfected using TransMessenger  Transfection
Reagent (Qiagen). After 3 h, cells were fed with normal med-
ium and then harvested 4 h later by washing with PBS and
lysing in 100 ml of Passive Lysis Buffer (Promega).
Luciferase assays
The activities of ﬁreﬂy (Fluc) and Renilla (Rluc) luciferase
were determined from cell lysates following transient trans-
fection. Assays were performed using 40 ml of cell lysate per
assay in the Dual-Luciferase Reporter Assay System (Pro-
mega) with a Thermal Labs Luminoskan Ascent luminometer.
For the dicistronic reporter assay, the relative ratio was cal-
culated by dividing the ﬁreﬂy luciferase activity by the Renilla
luciferase activity, then normalizing to the ratio calculated for
the negative control, pRF with no insert, whose value was set
to 1.0. For the promoterless reporter assay, the relative luci-
ferase ratio was normalized to the negative control, in this case
the IRES with no promoter activity, CrPV. Each reported
value is the mean from three independent transfections
(28). The absolute values for relative luciferase activities var-
ied from experiment to experiment, but the relative values
were consistent. Therefore the data shown in each ﬁgure
were collected together in one experiment.
Northern analysis
A total of 4 mg of polyA + RNA (Oligotex Direct, Qiagen,
Inc.) isolated 48 h after DNA transfection were separated
on 1% formaldehyde-agarose gels and transferred to Hybond
N+ (Amersham Biosciences). A gel-puriﬁed Fluc fragment
(NcoI to XbaI of pRF) was radiolabeled with
32P (Prime-a-
probe, Amersham Biosciences). Hybridization and washing
Nucleic Acids Research, 2006, Vol. 34, No. 3 855were carried out using Rapid-hyb (Amersham Biosciences) as
recommended by the manufacturer.
In vitro translation
RNA was transcribed in vitro using T7 polymerase (MAXI-
script, Ambion, Inc.) with templates made from dicistronic
luciferase constructs after linearization with XbaI. These
uncapped transcripts were translated in the presence of
35S-methionine (Amersham Biosciences) using rabbit reticu-
locyte lysate (Promega). Translation products were separated
by SDS–PAGE (12% acrylamide); phosphorimages were
analyzed with ImageQuant (Molecular Dynamics).
Autonomous retrotransposition assay
Retrotransposition assays were essentially as described (29)
using 143B osteosarcoma cells. Brieﬂy, 2.5 · 10
5 143B cells
were seeded in each well of a 6-well plate the day before
transfection. Cells were transfected with 2 mg of DNA
using LipoFectamine 2000 as recommended (Invitrogen).
Cells were selected for transfection with 10 mg/ml puromycin
24 h post-transfection. Cells were then harvested after 96 h of
puromycin selection and ﬂow cytometry was performed using
a FACS Calibur ﬂow cytometer (Becton Dickenson).
RESULTS
EvidenceforanIRESupstreamofbothORF1andORF2
in mouse L1
L1 sequences were tested in pRF, a dicistronic reporter vector.
This vector contains Rluc cloned downstream of a composite
SV40/T7 promoter as the ﬁrst cistron, and Fluc as the second
cistron. A highly structured element, DEMCV, between the
two reporter genes but upstream of the cloning site for the
IRES candidate sequences from L1, provides an effective
barriertoexpression ofﬁreﬂyluciferasebyread-through trans-
lation (Figure 1B). Stimulation of Fluc expression is indicative
of IRES activity (25). The known CrPV intergenic IRES
serves as a positive control.
Mouse L1 sequences extending 50 of the initial AUGs of
both ORF1 and ORF2 (Figure 1A), as well as several
sequences taken from the 30 end of ORF2 or the 30-UTR
that vary in their length and GC-content, were examined
for IRES activity. To test whether an IRES is present upstream
of ORF1, a construct containing 400 nt upstream of the ﬁrst L1
AUG was cloned into pRF (400-1 UTR). This region was
chosen as a starting point in an attempt to avoid the known
promoter activity of the monomer region; promoter activity is
minimalwithoneorlessmonomer, andincreaseswith increas-
ing copies of monomers (17). Brieﬂy, 400-1 UTR activated
translation of the Fluc at least as well as that of the positive
control, CrPV [(28), Figure 1C]. Likewise, a robust stimula-
tion of Fluc expression was detected when an L1 fragment
extending 201 nt upstream of the ORF2 AUG was tested
(201-1 IGR, Figure 1C). In contrast, all of the other regions
of L1 tested showed expression of Fluc similar to the empty
vector (Figure 1C), pRF, demonstrating that the ability to
function as an IRES is not a general feature of L1 sequence.
Four additional assays were used to test whether translation
of monocistronic transcripts, rather than IRES activity on a
dicistronic transcript, is responsible for Fluc expression. First,
RNA was isolated from the cells transfected with the dicis-
tronic vector containing 400-1 UTR or 201-1 IGR in order to
determine whether a shorter monocistronic RNA was detect-
able that could account for expression of Fluc. The expected
4.4 kb dicistronic transcript, but no smaller transcript, was
detected by northern hybridization using the ﬁreﬂy luciferase
cDNA probe (Figure 2A).
Second, these regions of L1 were tested in a promoterless
dicistronic reporter vector to evaluate whether they contain
cryptic promoters. The creation of truncated, monocistronic
RNAs by cryptic promoters in the test sequences is an alter-
native mechanism that would elevate Fluc expression in
these constructs (27). The known CrPV IRES was used as a
negative control because this sequence is known to function
as an IRES rather than a promoter (28). The 312 nt from the 30-
UTR of L1, which had no detectable IRES activity in pRF
(Figure 1), was also inactive in the context of the promoterless
construct (Figure 3), with Fluc values equivalent to CrPV
(Table 1). Brieﬂy 400-1 UTR and 201-1 IGR from L1
were both more active than CrPV and 312 in this assay
(Figure 3 and Table 1), suggesting that they both contain
weak cryptic promoters.
It appears that some of the Fluc expression driven by either
400-1 UTR or 201-1 IGR from L1 is accounted for by a cryptic
promoter in each of these sequences, with the greatest pro-
moter activity residing within the 400-1 UTR. However, these
activities are very weak compared with the 50 end of mouse
TrkB (containing exon 1 and 2), which contains a cryptic
promoter that is strong enough to produce a truncated
mRNA that can be readily detected by northern blot hybridi-
zation (Figure 2B). In addition, if Fluc expression in the
promoter-containing dicistronic vector is due to a combination
of translation by IRES activity from a dicistronic mRNA and
promoter activity from a truncated monocistronic RNA, then
the Fluc activity seen in the promoterless assay (where dicis-
tronic mRNA is eliminated as seen by the Rluc values in
Table 1) must represent the activity due to the cryptic promo-
ter. Since this accounts for only a fraction of the total Fluc
Figure 2. NorthernblotanalysisofFlucRNA.Phosphorimageofnorthernblot
ofRNArecoveredfromDNAtransfectionofthedicistronicconstructscontain-
ing L1 (A) or TrkB (B) sequences as indicated. Blots were hybridized to Fluc.
Thepositionsofsizestandardsrunintheadjacentlaneareindicated.Full-length
dicistronic transcripts are indicated by the arrows; the truncated TrkB Fluc
transcript from the cryptic promoter is indicated by the open arrowhead. The
coding sequence for Fluc is 1656 nt.
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to be due to IRES activity in both of the L1 sequences tested. It
is not unexpected that the 400-1 UTR had weak promoter
activity, because this region exhibits weak promoter activity
(10% of full-length TFspa, which is 2-fold over background)
in a monocistronic reporter gene assay (17).
Third, dicistronic mRNAs containing 400-1 UTR and 201-1
IGR were transcribed in vitro and then transfected into cells to
assay for Fluc and Rluc activity. The dicistronic reporter assay
with in vitro transcribed RNA is effective for identifying
IRESes because it bypasses the possibility of Fluc expression
from monocistronic RNAs created by cryptic promoter and
splicing activities. Both of these L1-containing constructs
showed similar Fluc expression as the CrPV IGR IRES
(Figure 4), further supporting the presence of an IRES
upstream of both ORF1 and ORF2 in mouse L1 RNA.
RNA transfections of the same constructs have been reported
to show lower activities than DNA transfections for some
cellular IRESes. To explain this anomaly, it was proposed
that the mRNA undergoes ‘nuclear events’ that are important
for IRES function by virtue of being transcribed in the
nucleus (30–32). Such a discrepancy between DNA and
RNA transfection for the dicistronic reporter assay was also
observed for the ORF2 IRES; 201-1 IGR was twice as active
as CrPV when DNA was transfected (Figure 1C), but was
at the same level as CrPV when RNA was transfected
(Figure 4). This discrepancy is even more dramatic if one
considers the fact that 400-1 UTR has some cryptic promoter
activity, which is negligible in 201-1 IGR (Figure 3). It is
possible that 201-1 IGR requires a ‘nuclear event’ to function
optimally as an IRES, which did not occur when the in vitro
transcript was transfected.
Finally, if the sequences between Rluc and Fluc are truly
acting to recruit ribosomes by internal initiation, then transla-
tion of the second cistron, Fluc, should be independent of
the translation of Rluc (28,33). To test this, we used
in vitro translation in rabbit reticulocyte lysates programmed
with RNA made in vitro using T7 polymerase. The L1
sequences under investigation were again cloned between
the two luciferases. In contrast to the transfection assays
above, however, Rluc was preceded by either an active
IRES from EMCV, or the inactive DEMCV sequence, render-
ing its translation either robust or nearly undetectable, respec-
tively. In spite of the dramatic reduction in the amount
of Rluc protein (compare the Rluc signals in Figure 5A
and B), the amounts of Fluc remained the same in constructs
containing either of the two L1 IRESes or the CrPV IRES
(Figure 5A and B).
Collectively, the results of these ﬁve assays argue strongly
that mouse L1 sequences upstream of ORF1 and ORF2 pro-
mote internal initiation of translation on dicistronic mRNAs,
rather than the creation of monocistronic mRNAs that are then
translated by a classic cap-dependent mechanism.
Figure 3. Promoterless vector assays. (A) Schematic of promoterless vector,
the arrow indicates the insertion site of the test sequences. (B) Relative luci-
ferase activities (to CrPV ± SD) of the 400 nt (400-1 UTR) or 201 nt (201-1
IGR)upstreamofORF1andORF2comparedwith312(L130-UTR)andmouse
TrkB(exon1and2)areplottedbelowtheschematicofthepromoterlessvector.
ThisregionofTrkBcontainsacrypticpromoter(Figure2).312isalsodevoidof
activity in the dicistronic assay of Figure 1.
Table 1. Rluc and Fluc activities from dicistronic reporter constructs
With promoter Without promoter
Rluc Fluc Rluc Fluc
400-1 UTR 208.74 ± 18.43 26.59 ± 0.81 0.06 ± 0.00 4.47 ± 0.31
201-1 IGR 324.29 ± 21.67 72.84 ± 11.08 0.06 ± 0.02 0.77 ± 0.18
CrPV 282.54 ± 35.88 28.26 ± 4.16 0.06 ± 0.00 0.36 ± 0.05
312 309.49 ± 28.51 2.82 ± 0.08 0.08 ± 0.01 0.32 ± 0.02
pRF 240.77 ± 56.95 1.75 ± 0.37 ND ND
TrkB ND ND 0.08 ± 0.01 78.59 ± 5.04
Mock 0.06 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.07 ± 0.01
Blank 0.07 0.08 0.07 0.08
Average and SD luminometer readings for triplicate samples after transfection
with promoter-containing versus promoterless dicistronic reporter constructs
(Figures 1 and 3). Mock, untransfected cells; blank, no cells; ND, not
determined.
Figure 4. RNAtransfection.Relativeluciferaseactivity(topRF ± SD)follow-
ingtransfectionofRNAtranscribedin vitrofrompRFconstructsasdepictedin
Figure 1.
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pRF constructs containing progressive truncations from the 50
or 30 end, or both, of 400-1 UTR were tested in the dicistronic
and promoterless reporter assay in an attempt to localize the
sequences important for the ORF1 IRES. Figure 6 shows the
relative luciferase activities obtained from these fragments in
both the dicistronic and promoterless constructs. Removing
100 nt from the 50 end partially reduced the IRES activity, but
the additional deletion of 100 or 200 nt did not lead to sig-
niﬁcant loss of IRES activity. The shortest 44 nt sequence
tested was signiﬁcantly reduced, but still retained 5-fold
IRES activity over background (Figure 6A, middle panel).
Although the longer constructs did have minimal cryptic pro-
moter activity, neither of the shorter two constructs did
(Figure 6A, right panel). A similar series of 30 truncations
were also tested. Removing 100 nt from the 30 end had a
similar effect to removing 100 nt from the 50 end. Unlike
the 50 end truncations, however, removing an additional
100 nt, or more, from the 30 end eliminated IRES activity
(Figure 6B, middle panel). These data suggest that the essen-
tial sequence lies within the 200 nt immediately upstream of
the ORF1 AUG. Consistent with this, when 100 nt fragments
across the region were tested, the two 30-most fragments
(101-1 and 199-102) had IRES activity, but the 50-most frag-
ment (401-310) did not. Surprisingly, fragment 302-202 also
had robust IRES activity (Figure 6C, middle panel). This was
unexpected because deleting this sequence from the 50 end of
299-1 had no effect on the activity (compare 299-1 and 199-1
in Figure 6A). It was also intriguing to see that both 302-202
and 199-102 were as active as 400-1 (Figure 6C, middle
panel). This could be due to the presence of an inhibitory
sequence in 400-1 that reduces the combined activity of
302-202 and 199-102 to the level of 400-1. If this is true,
then 302-102 would be expected to have even higher IRES
activity than 400-1. Remarkably, 302-102 is at best a weak
IRES. The activities of the other two 200 nt constructs were
also reduced relative to the 100 nt segments that comprised
them (Figure 6C and D, middle panel).
Taken together, these data indicate that the IRES activity is
largely conﬁned to the 300 nt upstream of ORF1. The data
further suggest that the activity depends upon RNA secondary
structure rather than the sequences per se. It is likely that the
RNA secondary structure is altered by these various sequence
juxtapositions, causing the IRES function to appear or disap-
pear. Indeed, Mfold analysis(34) predicted that 302-102forms
a structure very different than those formed by either 302-202
or 199-102 alone.
Mapping of the ORF2 IRES
A series of deletions in the 201-1 IGR construct were also
tested in the dicistronic and promoterless reporter systems to
delineate the region with IRES activity upstream of ORF2
(Figure 7A, middle and right panel). These deletions were
based on the results of an Mfold analysis of 201-1 (34),
which predicted very little stable secondary structure in this
region of mouse L1. However, one signiﬁcant stem–loop was
consistently found in the most stable thermodynamically
equivalent structures even when 201-1 was analyzed in the
context of much longer surrounding L1 sequences (data not
shown).Thispredicted stem–loop was the speciﬁc target of the
deletion constructs. A total of 63 nt were deleted from the
50 end of 201-1 (138-1) to just 50 of the putative stem–loop.
This deletion had reduced, but still signiﬁcant IRES activity
(Figure 7A, middle panel) and also eliminated all evidence of
cryptic promoter activity (Figure 7A, right panel). A further
deletion of 52 nt, removing the predicted stem–loop, reduced
Fluc expression to background levels (86-1), whereas the 53 nt
alone (138-86) had activity similar to 138-1 and CrPV
(Figure 7A, middle panel). To directly test the importance
of the L1 IGR for ORF2 IRES activity, those 40 nt were
removed from 201-1 to make 201-41, which retained the
IRES activity of 138-1 and 138-86. The 40 nt IGR alone,
40-1, like 86-1, was inactive (Figure 7A, middle panel).
These results demonstrate that the IGR is not required for
successful translation of the second cistron and place impor-
tant sequences for translational initiation of ORF2 within the
coding sequence of ORF1 (Figure 7A).
To further assess the signiﬁcance of the putative stem–loop,
we introduced three point mutations designed to disrupt base
pairing and hence its formation. This modiﬁed sequence actu-
ally increased the apparent translation of Fluc (Figure 7B,
middle panel, compare 138-1 with mut1), strongly suggesting
that formation of this stem–loop is not important for IRES
function. Consistent with this conclusion, introduction of three
additional point mutations that restored complementarity to
the stem–loop of mut1, to make mut2, effectively destroyed
IRES activity (Figure 7B, middle panel, compare 138-1 and
mut2). The 50-most point mutation in mut2 inadvertently intro-
duced an upstream AUG, which was followed by two in frame
stop codons 27 nt downstream (Figure 7B, left panel). Because
this small uORF would likely affect translation of Fluc, 1 bp
was exchanged to eliminate the introduced AUG, to create
mut4. The equivalent base pair exchange was also made in
mut1, creating mut3, to allow direct comparison of the dis-
rupted and restored stem–loop structures without the compli-
cation of the uORF (Figure 7B, middle panel). Both mut3 and
mut4 had higher apparent IRES activity than the original mut1
and mut2 (Figure 7B, middle panel). It is difﬁcult to discern,
however, whetherthisisarealincreaseinIRES activity,orifit
is caused by the slight increase in cryptic promoter activity
(Figure 7B, right panel). Nonetheless, one can conclude that
Figure 5. Test of translational independence of the second cistron in the
dicistronic reporter construct. Phosphorimages of SDS–PAGE gels containing
proteins labeled with [
35S]methionine during in vitro translation. Rabbit reti-
culocyte lysates were programmed with 20 ng/ml of dicistronic RNA tran-
scribed in vitro by T7 polymerase as indicated. Rluc translation is
controlled by either the EMCV IRES (A), or DEMCV (B), Fluc translation
is controlled by the three indicated sequences. Results identical to these were
obtained using 10 ng/ml of RNA in separate reactions.
858 Nucleic Acids Research, 2006, Vol. 34, No. 3Figure6.MappingtheORF1IRES.SchematicsofdeletionconstructsupstreamofORF1areshownontheleft.TheseregionsofL1wereclonedintoeitherpRForthe
promoterlessvectorandtestedforluciferaseexpression;relativeluciferaseactivitiesareplottedafternormalizationtopRF(dicistrionic,middle)ortotheCrPVIRES
(promoterless, right). (A)5 0 truncation series, (B)3 0 truncation series, (C) 100 nt fragments and (D) 200 nt fragments as indicated.
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inadvertent uORF, but rather due to one or more of the 3 nt
substitutions that distinguish it from mut1. This is likewise the
case for mut3 and mut4. Additionally, in both pairs of mutants
Fluc translationisfacilitatedby the ntsubstitutions thatdisrupt
base pairing, and severely impaired when base pairing is
restored (compare mut1 to mut2, and mut3 to mut4 in
Figure 7B, middle panel). The free energies of the predicted
stem–loops are virtually identical among the original wt
L1 sequence of 138-1, mut2 and mut4 ( 3.4,  3.7 and
 3.7 kcal/mol, respectively), yet Fluc expression in wt is
equivalent to the known IRES in CrPV, whereas mut2 and
mut4 are more like that of the negative control, pRF
(Figure7B,middlepanel).Theﬁndingthatrestoredbasepairing
inactivates the IRES suggests that speciﬁc sequences in 138-86,
and not simply the melting of the stem–loop structure (35), are
important for the function of the ORF2 IRES in mouse L1.
ORF2 translation and L1 retrotransposition
Naturally expressed mouse ORF2 protein has only been
detected indirectly by the requirement for its activities during
retrotransposition (18). This requirement was determined
using the autononomous retrotransposition assay, which
detects L1 retrotransposition events by expression of an
antisense-intron marked reporter gene (36). We used the
autonomous retrotransposition assay to examine the impor-
tance of the IGR and the putative stem–loop for ORF2 transla-
tion, as well as to test whether a ribosomal frameshift in the
overlapping region of ORF1 and ORF2 in mouse L1 is respon-
sible for ORF2 translation (37). As shown in Table 2, deletion
of the IGR caused a modest decrease in retrotransposition
frequency, similar to the decrease observed with the same
deletion in the dicistronic reporter gene assay, conﬁrming
that the IGR is not crucial for translation of ORF2. It was
also possible to introduce the three single nucleotide substitu-
tions of mut1 into the retrotransposition vector, since these are
silent in ORF1p. Retrotransposition of TFCmut1 was indistin-
guishable from wt, also consistent with the results of the dicis-
tronic assays. Mut2-4 were not tested because they altered the
sequence of ORF1, which is essential for retrotransposition
(9,36,38). To test whether a frameshift translates ORF2 during
L1 retrotransposition, a UAA stop codon was introduced just
50 of the ﬁrst AUG in ORF2. This mutant retrotransposed
Figure 7. Mappingthe ORF2IRES.(A) Truncations andfragmentsofthe ORF2IREStestedin thedicistronicreporterassaywith(dicistronic,middle)andwithout
(promoterless,right)apromoter.RelativeluciferaseactivitiesareplottedasinFigure6.(B)Theindicatedpointmutationsintheputativestem–looptestedasin(A),
point mutations are underlined, the new AUG in mut 2 and the resulting in frame stop codons (UAAUAA) are boxed.
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translated by a ribosomal frameshift between ORF1 and
ORF2. Intriguingly, introduction of a UAA just 30 of the
ﬁrst AUG in ORF2 also failed to abolish retrotransposition.
Because the next downstream AUG in ORF2 is 30 of critical
residues in the endonuclease domain (11), ORF2 translation
must not be strictly AUG dependent.
DISCUSSION
Dicistronic mRNAs are generally considered rare in eukar-
yotes, although perhaps this view should be reconsidered
given that the  3000 active (39) dicistronic copies of L1 in
the mouse comprise roughly 1% of its genome. Because inser-
tion of a new, full-length copy of L1 (e.g. retrotransposition)
requires the products of both ORFs (36) to be supplied in cis
(14,15), L1 RNA is necessarily dicistronic when its two ORFs
are translated. This feature, taken together with the enormous
potential for heterogeneity in both length and base composi-
tion of the region upstream of ORF1 in mouse L1, suggests
that neither ofthese two proteins could beefﬁcientlytranslated
by the standard cap-dependent recognition system followed by
ribosomescanning totheﬁrst AUG. Analternative mechanism
for translational initiation is to recruit ribosomes internally,
using an IRES. IRESes are found in a wide variety of viral and
cellular RNAs, and are functionally deﬁned by their ability to
promote independent translation of the second cistron in a
dicistronic RNA (40). By this criterion, the data presented
here demonstrate that the sequences upstream of both
ORF1 and ORF2 in mouse L1 RNA are IRESes.
Results of dicistronic reporter assays using 50 and 30 trun-
cated sequences, as well as four internal 100 nt fragments,
localizedthe ORF1IRESto the300nt50 ofthe ﬁrst AUG.This
conclusion is based upon three observations: (i) in the 50 trun-
cation series there was a progressive reduction, but never
complete loss of activity, even when only 44 nt of the 50-
UTR remained; (ii) complete loss of IRES function was
observed when the 30 200 nt were removed in the 30 truncation
series, suggesting that the 30 200 nt are critical; (iii) the three 30
100 nt fragments, but not the 50 92 nt, had IRES activity.
Interestingly, when two active, adjacent 100 nt fragments
were joined to form 200 nt fragments, IRES activity was
signiﬁcantly decreased compared with the 100 nt fragments
alone (Figure 6C and D). Similar modular activities have been
reported for other cellular IRESes, including TrkB (41), c-myc
(42), N-myc (43) and L-myc (44). These L1 results raise the
possibility that RNA structure is critical for the function of the
ORF1 IRES, which is common for viral IRESes (45–48) as
well as some cellular IRESes (35,44,49).
The ORF2 IRES was localized to 53 nt in the 30 end of
ORF1. Surprisingly, the IGR was not required for either IRES
function or L1 retrotransposition, since greater than half of
these activities remained when the IGR was deleted. Although
the highest IRES activity was observed with the longest con-
struct (201-1), any deletion that retained the 53 nt region of
ORF1, including the 53 nt alone, maintained robust IRES
activity. In contrast, any construct with these 53 nt deleted
lost IRES activity. The loss of activity between 201-1 and
138-1 may simply be due to elimination of the small amount
of cryptic promoter activity in 201-1 (Figure 7B). Alterna-
tively, because removing either the 50 63 nt or the IGR reduces
IRES activity equally, an interaction between these two
regions may enhance IRES activity. Just three point mutations,
those that distinguish mut4 from mut3 and mut2 from mut1, in
the 53 nt IRES destroyed activity, demonstrating that IRES
function is abolished by one or more of these changes. These
mutations may disrupt a direct interaction with the 40S subunit
(50), or a factor that recruits the 40S subunit, e.g. an IRES
trans-acting factor [ITAF (20,21)].
These experimental results also provide new information to
address the question of how ORF2 is translated. Because
ORF1 and ORF2 in mouse L1 overlap by 14 nt, it is theore-
tically possible that ORF2 could be translated by a +1 frame-
shift of the ribosome during elongation on ORF1 (37).
Furthermore, ribosomal frameshifting is a widely-used
mechanism for translation of the enzymatic components of
other retrotransposons and retroviruses (51), which is exactly
the role of ORF2 in L1 retrotransposition. To test the possi-
bility that a frameshift is used to translate mouse ORF2, a stop
codon was introduced just 50 of the ﬁrst AUG in ORF2. Retro-
transposition of L1 was unaffected, if not improved (Table 2),
effectively ruling out a role for frameshifting in the translation
of ORF2 in mouse L1. This ﬁnding is consistent with experi-
ments that eliminated frameshifting for human (52) and rat L1
(53). Given the juxtaposition of ORF2 relative to ORF1, rein-
itiation following ORF1 translation is another possibility.
Ribosomal reinitation was ﬁrst revealed in studies of the
yeast GCN4 gene and has more recently been documented
for the ATF4 gene in mammals (23). Translational coupling
is also formally a possibility and has been shown to be respon-
sible for translation of the ORF2 protein in the non-LTR-
retrotransposon SART1 (54). However, translation of the
downstream ORF by either of these mechanisms is dependent
upon translation of the uORF. This is not the case for the L1
ORF2 IRES based upon our in vitro translation data, where
translation of the downstream ORF occurs independently of
translation of the uORF (Figure 5). These ﬁndings argue
against ORF2 translation by frameshifting, ribosome reinita-
tion or translational coupling in mouse L1.
How are translation of ORF1 and ORF2 regulated during
retrotransposition? Although the stoichiometry of ORF1p,
ORF2p and L1 RNA in the L1 RNP is unknown, ORF1p
binds sequence non-speciﬁcally to RNA with high afﬁnity
(7). The protein binds as a homotrimer (55), with each trimer
occupying 50 nt (56). Large RNPs containing ORF1p and
Table 2. Retrotransposition frequency of mouse L1 with mutations to test
ORF2 translation
Construct % Green fluorescent protein (GFP)
TFC 4.83 ± 0.12
IRES control 4.70 ± 0.17
DIGR 2.50 ± 0.26
UAA-AUG 5.80 ± 0.26
AUG-UAA 2.00 ± 0.10
TFCmut1 5.00 ± 0.10
IRES control contains a silent substitution in ORF2 that introduces a HpaI site
for cloning into TFC element (9), all other constructs are derived from it as
indicated by the name: DIGR has the IGR between ORF1 and ORF2 removed,
juxtaposingtheUAAstopofORF1withtheAUGstartofORF2.UAA-AUGhas
a stop codon inserted immediately 50, and AUG-UAA immediately 30, of the
ORF2 AUG. TFCmut1 contains the 3 nt substitutions of mut1 in Figure 7.
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(4,57,58) and are known to be a necessary intermediate in
L1 retrotransposition (38). Assuming that the ﬁnal RNP com-
plex contains full-length L1 RNA (7521 nt) coated with
ORF1p, 450 translations of ORF1 are needed. On the other
hand, ORF2p contains endonuclease and reverse transcriptase
activities, and is likely needed in just one or two copies for the
TPRT reaction (59,60). Because ORF2p overexpression is
highly toxic to cells (61,62), it is likely critical that ORF2
translation is tightly controlled, such that far less is made
compared with ORF1p. Yet in our dicistronic reporter assays,
there is little difference between the efﬁciencies of the
sequences upstream of the ORF1 or ORF2 AUG in promoting
Fluc expression. In order to explain the paradox that both
IRESes appear similarly efﬁcient in our assays, even though
far fewer translations of ORF2 than of ORF1 are required for
L1 retrotransposition, we propose a model whereby ORF1
translation inactivates the ORF2 IRES. In this model, the
ﬁrst round of translation is initiated efﬁciently on both
ORF1 and ORF2. However, once ORF1 is translated, the
ORF2 IRES is inactivated, thereby stopping all further
translation of ORF2. This could be achieved by ORF1p bind-
ing to L1 RNA immediately as it is released from the ribo-
some, which is in the near vicinity of the ORF2 IRES. If the
ORF2 IRES uses a land and scan mechanism as reported for c-
myc, L-myc and Apaf1 (35,44,49), perhaps ORF1 protein
bound to the IGR simply blocks 43S ribosome scanning.
Self-regulation in IRES-mediated translational initiation has
been proposed for Ideﬁx, an LTR-retrotransposon in Droso-
phila melanogaster (63) and HCV (64,65), although neither of
these are dicistronic mRNAs. Alternatively, it may be that the
ORF2 IRES is only recognized when bound by an ITAF (20),
perhaps added as a consequence of the nuclear experience.
Once a ribosome elongating through ORF1 causes this factor
to dissociate, the ORF2 IRES is silenced. Additional experi-
ments are needed to test the predictions of these models.
Signiﬁcantly, neither of the two regions in mouse L1 iden-
tiﬁed in this study as IRESes are well-conserved among mam-
malian L1s. The 50 end of L1, including the promoter, 50-UTR
and N-terminal third of ORF1, appears to have an independent
evolutionary origin in humans, rodents and rabbits, rather than
being related by descent [reviewed in (2)]. Thus, the mouse L1
sequence containing the ORF1 IRES detected here is not
shared among mammalian L1s. Another signiﬁcant difference
between the 50-UTRs of the mouse and human elements is that
human L1 typically contains at least one AUG upstream of
ORF1 (52), whereas mouse L1 does not. In contrast, the ORF2
IRES is in a region that is homologous among mammalian L1s
(37), but within that region the sequences surrounding the
ORF2 AUG, particularly extending to the 50, are strikingly
divergent (Figure 8). The sequences encompassing the last
eight amino acids of ORF1 and the ﬁrst seven amino acids
of ORF2 as well as the IGR in mouse and human L1 are
difﬁcult to align. There are also several differences between
mouse and human elements in sequences that are signiﬁcant
for translation: the mouse IGR is 40 nt, has no AUGs and has
just one termination codon (UAA) in the third reading frame
that does not encode either ORF1 or ORF2; the human IGR is
63 nt (keeping ORF1 and ORF2 in the same frame) and con-
tains an AUG as well as ﬁve stop codons with at least one in
each of the three reading frames. Intriguingly, one of these
stop codons overlaps the ORF2 AUG, creating the sequence
UAAUG, which is identical to the sequence associated with
translational coupling for ORF2 expression in SART1 (54).
Furthermore, a strong stem–loop structure, similar to one
required for the translation of SART1 ORF2, can be found
downstream of the ORF2 AUG in human L1 by Mfold ana-
lysis. Neither the overlapping stop-start codon, nor the struc-
tural element is evident in mouse L1. These sequence
differences likely indicate, or even necessitate, the use of
different strategies for initiation of translation of ORF2 in
mouse compared with human L1. It is intriguing to speculate
Figure 8. Rapid evolution in the IGR of L1. (A) VISTA plot (http://genome.lbl.gov/vista/mvista/submit.shtml) to visualize sequence similarity between mouse L1
andrat(top)orhuman(bottom)fromtheconservedregionofORF1[aminoacid150(55)]throughtheconservedendonucleasedomainsofORF2(10)includingthe
IGR. Percent identity (between 50–100%) is plotted for 100 nt windows across the length compared, gray fills are regions with at least 60% identity for 100 nt.
(B)EnlargementoftheIGRofmouseL1alignedwiththehomologousratandhumansequences.SequencebeginsinthepoorlyconservedC-terminalregionofORF1
andextendsthroughthefirstAUGofhumanORF2.TheORF1stopandORF2startcodonsareboldandunderlinedinallthreesequences;theAUGsintheIGRofrat
andhumanareboldandcapitalized,asaretheirinframestopswhichwouldleadtotranslationof18or6aminoacidspeptides,respectively.BothoftheseuORFsinthe
IGR require a +1 frameshift to match the frame of the ORF2 AUG.
862 Nucleic Acids Research, 2006, Vol. 34, No. 3that these regions could be targets for regulation (and perhaps
suppression) of L1 retrotransposition by altering the trans-
lation of ORF1p and ORF2p. If this is the case, the high
sequence divergence observed between transposition-
competent mouse and human L1s may indicate a shift in
the strategy used by L1 in these two species to recruit ribo-
somesfor translationof both ofthe L1-encoded essential retro-
transposition proteins. Thus the rapid evolution of this region
may reﬂect positive selection to either attract enhancers or lose
inhibitors that regulate translation of ORF2 in L1 mRNA,
rather than a lack of functional constraints.
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